Free Trial

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Up 243.1% in January

Bayer Aktiengesellschaft logo with Medical background

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,536,000 shares, an increase of 243.1% from the January 15th total of 447,700 shares. Based on an average daily trading volume, of 2,008,300 shares, the short-interest ratio is presently 0.8 days.

Bayer Aktiengesellschaft Price Performance

BAYRY stock traded down $0.05 during midday trading on Friday, reaching $5.65. The company had a trading volume of 519,052 shares, compared to its average volume of 1,011,742. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. Bayer Aktiengesellschaft has a 1 year low of $4.79 and a 1 year high of $8.58. The company has a market capitalization of $22.20 billion, a P/E ratio of -21.73 and a beta of 1.04. The firm has a 50-day moving average price of $5.26 and a 200-day moving average price of $6.41.

Bayer Aktiengesellschaft Company Profile

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Featured Stories

Should You Invest $1,000 in Bayer Aktiengesellschaft Right Now?

Before you consider Bayer Aktiengesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.

While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Cashes In on Stocks—Here’s How You Can Too!
5 Stocks to BUY NOW in March 2025
Archer Aviation: Sinking Now, Soaring Soon?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines